Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

2.

Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease.

Roth MD, Tseng CH, Clements PJ, Furst DE, Tashkin DP, Goldin JG, Khanna D, Kleerup EC, Li N, Elashoff D, Elashoff RM; Scleroderma Lung Study Research Group.

Arthritis Rheum. 2011 Sep;63(9):2797-808. doi: 10.1002/art.30438.

3.

A long-term prospective randomized controlled study of non-specific interstitial pneumonia (NSIP) treatment in scleroderma.

Domiciano DS, Bonfá E, Borges CT, Kairalla RA, Capelozzi VL, Parra E, Christmann RB.

Clin Rheumatol. 2011 Feb;30(2):223-9. doi: 10.1007/s10067-010-1493-4. Epub 2010 Jun 11.

PMID:
20544245
4.

Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study.

Goldin J, Elashoff R, Kim HJ, Yan X, Lynch D, Strollo D, Roth MD, Clements P, Furst DE, Khanna D, Vasunilashorn S, Li G, Tashkin DP.

Chest. 2009 Nov;136(5):1333-40. doi: 10.1378/chest.09-0108.

5.

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, Roberts C, Desai S, Herrick AL, McHugh NJ, Foley NM, Pearson SB, Emery P, Veale DJ, Denton CP, Wells AU, Black CM, du Bois RM.

Arthritis Rheum. 2006 Dec;54(12):3962-70.

6.

Oral cyclophosphamide improves pulmonary function in scleroderma patients with fibrosing alveolitis: experience in one centre.

Beretta L, Caronni M, Raimondi M, Ponti A, Viscuso T, Origgi L, Scorza R.

Clin Rheumatol. 2007 Feb;26(2):168-72. Epub 2006 Apr 14.

PMID:
16614793
7.

Long-term follow-up of patients with scleroderma interstitial lung disease treated with intravenous cyclophosphamide pulse therapy: a single-center experience.

Balbir-Gurman A, Yigla M, Guralnik L, Hardak E, Solomonov A, Rozin AP, Toledano K, Dagan A, Bishara R, Markovits D, Nahir MA, Braun-Moscovici Y.

Isr Med Assoc J. 2015 Mar;17(3):150-6.

8.

Determinants of pulmonary function improvement in patients with scleroderma and interstitial lung disease.

Tzelepis GE, Plastiras SC, Karadimitrakis SP, Vlachoyiannopoulos PG.

Clin Exp Rheumatol. 2007 Sep-Oct;25(5):734-9.

PMID:
18078622
9.

Cyclophosphamide versus placebo in scleroderma lung disease.

Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M; Scleroderma Lung Study Research Group.

N Engl J Med. 2006 Jun 22;354(25):2655-66.

10.

Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial--results from the Scleroderma Lung Study.

Khanna D, Tseng CH, Furst DE, Clements PJ, Elashoff R, Roth M, Elashoff D, Tashkin DP; for Scleroderma Lung Study Investigators.

Rheumatology (Oxford). 2009 Dec;48(12):1537-40. doi: 10.1093/rheumatology/kep284. Epub 2009 Sep 23.

11.

Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.

Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin DP; Scleroderma Lung Study Group.

Arthritis Rheum. 2005 Feb;52(2):592-600.

12.

Oral cyclophosphamide for active scleroderma lung disease: a decision analysis.

Khanna D, Furst DE, Clements PJ, Tashkin DP, Eckman MH.

Med Decis Making. 2008 Nov-Dec;28(6):926-37. doi: 10.1177/0272989X08317015. Epub 2008 Apr 28.

PMID:
18443209
13.

Interstitial lung disease associated with systemic sclerosis: what is the evidence for efficacy of cyclophosphamide?

Bérezné A, Valeyre D, Ranque B, Guillevin L, Mouthon L.

Ann N Y Acad Sci. 2007 Sep;1110:271-84.

PMID:
17911442
14.

High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.

Wanchu A, Suryanaryana BS, Sharma S, Sharma A, Bambery P.

Int J Rheum Dis. 2009 Sep;12(3):239-42. doi: 10.1111/j.1756-185X.2009.01417.x.

PMID:
20374353
15.

Two-year experience with mycophenolate mofetil in patients with scleroderma lung disease: a case series.

Yilmaz N, Can M, Kocakaya D, Karakurt S, Yavuz S.

Int J Rheum Dis. 2014 Nov;17(8):923-8. doi: 10.1111/1756-185X.12399. Epub 2014 May 26.

PMID:
24864029
16.

Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders.

Iudici M, Cuomo G, Vettori S, Bocchino M, Sanduzzi Zamparelli A, Cappabianca S, Valentini G.

Semin Arthritis Rheum. 2015 Feb;44(4):437-44. doi: 10.1016/j.semarthrit.2014.09.003. Epub 2014 Sep 8.

PMID:
25282395
17.

Exhaled NO predicts cyclophosphamide response in scleroderma-related lung disease.

Tiev KP, Rivière S, Hua-Huy T, Cabane J, Dinh-Xuan AT.

Nitric Oxide. 2014 Aug 31;40:17-21. doi: 10.1016/j.niox.2014.04.011. Epub 2014 May 14.

PMID:
24831352
18.

Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis.

Colaci M, Sebastiani M, Giuggioli D, Manfredi A, Spagnolo P, Luppi F, Richeldi L, Ferri C.

Scand J Rheumatol. 2010 Mar;39(2):155-9. doi: 10.3109/03009740903270581.

PMID:
20059446
19.

Cyclophosphamide for scleroderma lung disease: a systematic review and meta-analysis.

Poormoghim H, Moradi Lakeh M, Mohammadipour M, Sodagari F, Toofaninjed N.

Rheumatol Int. 2012 Aug;32(8):2431-44. doi: 10.1007/s00296-011-1967-y. Epub 2011 Jun 21. Review.

PMID:
21691743
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk